[Mortality in Parkinson's disease and its modification by levodopa (author's transl)].
作者信息
Schneider E, Fischer P A, Jacobi P, Kolb R
出版信息
Fortschr Neurol Psychiatr. 1981 May;49(5):187-92. doi: 10.1055/s-2007-1002322.
PMID:7239405
Abstract
摘要
相似文献
1
[Mortality in Parkinson's disease and its modification by levodopa (author's transl)].帕金森病的死亡率及其左旋多巴的影响（作者译）
Fortschr Neurol Psychiatr. 1981 May;49(5):187-92. doi: 10.1055/s-2007-1002322.
2
[Contribution to the biochemical treatment of the Parkinson's disease (author's transl)].
Rev Esp Otoneurooftalmol Neurocir. 1978 Jan-Jun;36(204):33-41.
3
[Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
Nervenarzt. 1981 Feb;52(2):116-20.
4
Parkinson's disease: progression and mortality in the L-DOPA era.帕金森病：左旋多巴时代的病情进展与死亡率
Adv Neurol. 1996;69:3-11.
5
6
[CB 154 in the treatment of parkinson's disease--results of the association with L-DOPA + DDI (author's transl)].CB 154治疗帕金森病——与左旋多巴+脱羧酶抑制剂联合应用的结果（作者译）
Schweiz Rundsch Med Prax. 1976 May 4;65(18):557-9.
7
[Long-term prognostic factors in Parkinson's disease (author's transl)].
Rev Neurol (Paris). 1978 May;134(5):341-54.
8
Reply to Jack E. Riggs' "Deprenyl, excess mortality, and epidemiological traps". Parkinson's Disease Research Group of the United Kingdom.
Clin Neuropharmacol. 1998 Jul-Aug;21(4):265-6.
9
[Two cases of Parkinson's disease with diphasic dyskinesia, seen during levodopa treatment (author's transl)].
Rinsho Shinkeigaku. 1982 Mar;22(3):209-15.
10
[The association of L-DOPA and Ro 4-4602 in the treatment of Parkinson's disease (author's transl)].左旋多巴与Ro 4-4602联合治疗帕金森病（作者译）
Riv Patol Nerv Ment. 1974 Oct;95(5):673-5.
Zotero 插件